Status:
COMPLETED
Mental Health Assessment and Prescribing by Alberta Pharmacists
Lead Sponsor:
University of Alberta
Conditions:
Major Depressive Disorder
Generalized Anxiety Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a clinical trial evaluating the experimental intervention of enhanced pharmacist care by pharmacists with additional prescribing authorization (APA) in Alberta, for patients newly diagnosed wi...
Detailed Description
Primary objective -To evaluate the effect of enhanced pharmacist care possible by community pharmacists with APA in comparison with usual care (standard pharmacist care and physician care) for patien...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adults (≥ 18 years of age) newly diagnosed with MDD and/or GAD, including:
- Patients starting on medications for the management of adults with MDD
- Patients starting on medications for the management of GAD
- Exclusion Criteria:
- Pregnancy
- Non-Alberta residents
- Unwilling or unable to participate in regular follow-up visits
- Unwilling to participate/sign consent form
- ≥2 suicide attempts per year
- Severe, psychotic, and catatonic depression
- History of and/or current substance abuse, intoxication, addiction or withdrawal
- Patients diagnosed with comorbid anxiety disorders other than GAD, including: panic -disorder, agoraphobia, specific phobia, social anxiety disorder, obsessive-compulsive disorder, posttraumatic stress disorder
- Patients diagnosed with comorbid depressive disorder other than MDD, including: depressive disorder due to another medical condition (e.g. hypothyroidism, MS, OSA, -Parkinsons, stroke, TBI, Vitamin B12 insufficiency, Huntington disease, adrenal insufficiency, mononucleosis, systemic lupus erythematosus), adjustment disorder with depressed mood
- Patients diagnosed with concurrent ADHD, bipolar disorder, schizophrenia and schizoaffective disorder
Exclusion
Key Trial Info
Start Date :
March 22 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04410575
Start Date
March 22 2023
End Date
May 31 2025
Last Update
July 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2R3